Literature DB >> 15218962

Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma.

Koichiro Muta1, Koichi Ohshima, Yasunobu Abe, Naokuni Uike, Ilseung Choi, Takamitsu Matsushima, Junji Nishimura, Masahiro Kikuchi, Manabu Nakashima, Takeshi Watanabe, Hajime Nawata.   

Abstract

In human cancer, RCAS1 (the receptor-binding cancer antigen expressed on SiSo cells) on the surface of various kinds of tumor cells reportedly induces the apoptosis of T-cells and natural killer cells, resulting in evasion of the immune system. In the present study, an immunohistochemical analysis of RCAS1 expression was performed with lymph node specimens obtained from patients with adult T-cell leukemia/lymphoma (ATLL). Positive staining was seen in 15 (75%) of 20 cases and in all cases of patients with short survival times. In the cases of B-cell lymphomas, positive staining was seen in only 1 (13%) of 8 cases. These findings indicate that expression of RCAS1 may be associated with the evasion from immune surveillance of cells infected with human T-lymphotropic virus type I, resulting in the development of overt leukemia/lymphoma. Determination of RCAS1 expression may be useful for predicting the prognosis of patients with ATLL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218962     DOI: 10.1532/ijh97.03109

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.

Authors:  S Yashiki; T Fujiyoshi; N Arima; M Osame; M Yoshinaga; Y Nagata; M Tara; K Nomura; A Utsunomiya; S Hanada; K Tajima; S Sonoda
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

2.  Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.

Authors:  K Ohshima; K Muta; M Nakashima; S Haraoka; T Tutiya; J Suzumiya; C Kawasaki; T Watanabe; M Kikuchi
Journal:  Int J Cancer       Date:  2001-07-01       Impact factor: 7.396

3.  Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.

Authors:  K Ohshima; S Haraoka; M Sugihara; J Suzumiya; C Kawasaki; M Kanda; M Kikuchi
Journal:  Cancer Lett       Date:  2000-11-10       Impact factor: 8.679

4.  HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma.

Authors:  K Usuku; S Sonoda; M Osame; S Yashiki; K Takahashi; M Matsumoto; T Sawada; K Tsuji; M Tara; A Igata
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

5.  Establishment of a new human uterine cervical adenocarcinoma cell-line, siso, and its reactivity to anticancer reagents.

Authors:  K Sonoda; M Nakashima; T Saito; S Amada; T Kamura; H Nakano; T Watanabe
Journal:  Int J Oncol       Date:  1995-05       Impact factor: 5.650

Review 6.  HTLV-I Tax related dysfunction of cell cycle regulators and oncogenesis of adult T cell leukemia.

Authors:  N Arima; C Tei
Journal:  Leuk Lymphoma       Date:  2001-01

7.  Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

Authors:  S Strand; W J Hofmann; H Hug; M Müller; G Otto; D Strand; S M Mariani; W Stremmel; P H Krammer; P R Galle
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

8.  Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.

Authors:  K Sonoda; T Kaku; T Kamura; M Nakashima; T Watanabe; H Nakano
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

9.  Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin.

Authors:  Yasunobu Abe; Shinji Yashiki; Ilseung Choi; Keiichi Hara; Takamitsu Matsushima; Junji Nishimura; Shoichi Inaba; Hajime Nawata; Koichiro Muta
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 10.  The current status of therapy for adult T-cell leukaemia-lymphoma in Japan.

Authors:  Yasuaki Yamada; Masao Tomonaga
Journal:  Leuk Lymphoma       Date:  2003-04
View more
  3 in total

1.  The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers.

Authors:  Sahin Coban; Hasan Ozkan; Seyfettin Köklü; Osman Yüksel; Muhammed Cem Koçkar; Tarik Akar; Necati Ormeci
Journal:  Can J Gastroenterol       Date:  2006-09       Impact factor: 3.522

2.  Analysis of the intensity of immune cell infiltration and immunoreactivity of RCAS1 in diffuse large B-cell lymphoma of the palatine tonsil and its microenvironment.

Authors:  W Kazmierczak; A Lazar; R Tomaszewska; T J Popiela; K Koper; Lukasz Wicherek; M Dutsch-Wicherek
Journal:  Cell Tissue Res       Date:  2015-03-17       Impact factor: 5.249

3.  Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma.

Authors:  Hideaki Tanaka; Takeshi Toyoshima; Kenzo Sonoda; Ryoji Kitamura; Masaaki Sasaguri; Shintaro Kawano; Ryota Matsubara; Yuichi Goto; Seiji Nakamura
Journal:  J Transl Med       Date:  2014-05-06       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.